Ironwood Pharmaceuticals Stock Price and Value Analysis

Should you buy Ironwood Pharmaceuticals stock? (NasdaqGS:IRWD). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has wild ups and downs.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the IRWD Numbers

IRWD Price
(Ironwood Pharmaceuticals stock price per share)
$11.73
[?] PE Ratio versus Sector 12% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Unknown stocks
[?] Cash Yield -5.18%
[?] Free Cash Flow Jitter 71%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 18,311,768 shares shorted. With 143,667,735 shares available for purchase and an average trading volume over the past 10 trading days of 2,050,225, it would take at least 8.932 days for all of the short holders to cover their shorts.

Is Ironwood Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Ironwood Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy IRWD Stock?

Does Ironwood Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.